The Ovarian Cancer Institute is excited to announce a new campaign called #GNO4OCI (Girls Night for OCI) in honor of World Ovarian Cancer Day on May 8th. The concept is simple…gather your girlfriends and raise ovarian cancer awareness by hosting your own...
Thank you to the many donors and volunteers who contributed to this year’s success. It was amazing and we are ever thankful for helping us reach so many goals! Click the link below to view our 2017 annual report. OCI Annual Report...
Ten days ago marked the beginning of Ovarian Cancer Awareness month, the 4th one since I was diagnosed. I didn’t even know there was a month for it, so we all have work to do to continue to spread the word. I still have conversations every single week with people who...
This weekend marked my 3rd cancerversary. I’m pretty excited that I am stable at 3 years with late stage ovarian cancer. Every year, I go back and read the blog I started when I was first diagnosed. As I was going through that exercise, it occurred to me, this might...
The research update below was reported by our Chief Research Officer, Dr. John McDonald. OCI Progress Report 2016-2017 Thanks for this opportunity to summarize our progress over the past year (2016-2017). Our research focuses on both improved diagnostics and...
The Ovarian Cancer Institute is an innovative collaboration of noted gynecologic oncologist Benedict B. Benigno, M.D., and internationally recognized scientist John McDonald, Ph.D., Director of the Integrated Cancer Research Center at the Georgia Institute of Technology. Because of the relationship between Dr. Benigno and Dr. McDonald samples have been transfered from the operating room to the laboratory and over 2,000 ovarian cancer samples are now preserved, one of the largest sample banks and most extensive patient history database in the world.
OCI is not your traditional research institute. Often called a renegade, Dr. McDonald takes an “outside the box approach” to his work. Dr. McDonald integrates engineering, nanotechnology, medicine, computer science and chemistry to conduct his successful research. The laboratory uses an integrated systems approach to ovarian cancer research which only the Georgia Institute of Technology can provide.
The laboratory supported by OCI focuses on 3 major projects:
personalized cancer genomics profiling, working toward prescribing optimal and personalized therapies for ovarian cancer patients
targeted therapeutic delivery using nanotechnology
diagnostic test for ovarian cancer in Stage I or sooner which has been proven 100% sensitive and specific!
These statistics motivate the Ovarian Cancer Institute to continue the fight through research. Early detection is vital to survival and now that a test has been discovered, we will continue through the validation stage and look forward to successful results.
The mission of the Ovarian Cancer Institute is to develop innovative research leading to earlier detection and more effective control of ovarian cancer; to investigate newer modalities of treatment; and to heighten women’s awareness of the symptoms of, and treatment options for this disease.
(Tuesday) 11:00 am - 5:00 pm
Capital City Club Crabapple
4114 Earney Road
Ovarian Cancer Instituteinfo@ovariancancerinstitute.org